For women with gynecological cancer and malignant ascites undergoing paracentesis, what are the effects of catumaxomab?

Sera Tort, Jane Burch
In: Cochrane Clinical Answers · 2020 · doi:10.1002/cca.3122 · W3034825858
OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-09-11 ⓘ

The provided text contains only a research question regarding the effects of catumaxomab in women with gynecological cancer and malignant ascites undergoing paracentesis, as no abstract or results are available to summarize.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-21T06:41:41.500114+00:00
License: CC0 · commercial use OK